Parvimonas micra Causing Emphysematous Osteomyelitis: A Case Report. 2022

James Ghosen, and Christopher Lucasti, and Susan Daoust
University at Buffalo Jacobs School of Medicine, Buffalo, New York.

We present an interesting case of femoral emphysematous osteomyelitis (EO) in a 67-year-old patient with the offending pathogen to be Parvimonas micra. Two knee arthrotomies with lateral thigh exploration were performed to debride and irrigate the bone and compartments. Although the patient initially improved, definitive treatment with an antibiotic intramedullary rod was necessary and resulted in complete resolution. We present the first case of EO secondary to P. micra described in the literature and recommend aggressive surgical management for complete resolution and preserved functional outcome.

UI MeSH Term Description Entries
D010019 Osteomyelitis INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA. Osteomyelitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068536 Firmicutes A phylum of predominantly GRAM-POSITIVE BACTERIA that includes the orders Bacillales and Clostridiales. Firmicutes and BACTEROIDETES are the two bacterial phyla that constitute the majority of the human gut MICROBIOTA.
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D016908 Gram-Positive Bacterial Infections Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method. Bacterial Infections, Gram-Positive,Infections, Gram-Positive Bacterial,Bacterial Infection, Gram-Positive,Bacterial Infections, Gram Positive,Gram Positive Bacterial Infections,Gram-Positive Bacterial Infection,Infection, Gram-Positive Bacterial,Infections, Gram Positive Bacterial

Related Publications

James Ghosen, and Christopher Lucasti, and Susan Daoust
April 2021, BMC infectious diseases,
James Ghosen, and Christopher Lucasti, and Susan Daoust
April 2023, Journal of cardiothoracic surgery,
James Ghosen, and Christopher Lucasti, and Susan Daoust
November 2023, Cureus,
James Ghosen, and Christopher Lucasti, and Susan Daoust
September 2022, BMJ case reports,
James Ghosen, and Christopher Lucasti, and Susan Daoust
April 2021, Proceedings (Baylor University. Medical Center),
James Ghosen, and Christopher Lucasti, and Susan Daoust
May 2023, Journal of cardiothoracic surgery,
James Ghosen, and Christopher Lucasti, and Susan Daoust
March 2019, Journal of medical case reports,
James Ghosen, and Christopher Lucasti, and Susan Daoust
January 2023, Respiratory medicine case reports,
James Ghosen, and Christopher Lucasti, and Susan Daoust
September 2022, Healthcare (Basel, Switzerland),
James Ghosen, and Christopher Lucasti, and Susan Daoust
January 2023, World journal of emergency medicine,
Copied contents to your clipboard!